Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma
Background Resistance to immune checkpoint inhibitors (ICIs) significantly limits the efficacy of immunotherapy in patients with hepatocellular carcinoma (HCC). However, the mechanisms underlying immunotherapy resistance remain poorly understood. Our aim was to clarify the role of membrane-associate...
Saved in:
| Main Authors: | Qian Wang, Rui Peng, Chi Zhang, Jun Cao, Bingbing Su, Daoyuan Tu, Qiangwei Deng, Guoqing Jiang, Shengjie Jin, Dou-Sheng Bai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/11/e010157.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
by: Marjan Rafat, et al.
Published: (2020-05-01) -
Elucidating the synergistic roles of CD4+ T and dendritic cells in antitumor immunity
by: Xiubao Ren
Published: (2025-01-01) -
Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells
by: Zheng Huang, et al.
Published: (2024-03-01) -
PARP-1 Is Critical for Recruitment of Dendritic Cells to the Lung in a Mouse Model of Asthma but Dispensable for Their Differentiation and Function
by: Laura C. Echeverri Tirado, et al.
Published: (2019-01-01) -
Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response
by: Ming Yang, et al.
Published: (2020-10-01)